AURYXIA, created in 2014 (United States), from 4 sister brands and 2214 competing brands. AURYXIA is a brand of Akebia Therapeutics, listed on the stock exchange of New York. AURYXIA belongs to the Biotechnology business sector.

AURYXIA is a brand of Akebia Therapeutics (AKBA) Share price

International deposit : 2014 Business sector Biotechnology

Share price and profitability of the share Akebia Therapeutics (AURYXIA)

Buy Akebia Therapeutics share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.

Investment simulator :

Amount invested USD 1.35

Portfolio valuation
Akebia Therapeutics (AURYXIA) over 5 years* USD 0.29

Stock market history Akebia Therapeutics (AURYXIA)

*non inclusive of dividends, non inclusive of market orders
past performances do not prejudice future performances

Other brands
Akebia Therapeutics

Keryx Biopharmaceuticals
Keryx Biopharmaceuticals
See more brands of Akebia Therapeutics

Rival brands
AURYXIA

NOTABLE LABS
NOTABLE LABS
Roivant
Roivant
Valerio Therapeutics
Valerio Therapeutics
INVERSAGO
INVERSAGO
Terns Pharma
Terns Pharma
Vaxcyte
Vaxcyte
OTHER RIVAL BRANDS

Top Popularity Web

See the full ranking
Desirable brands that generate Pricing Power and therefore stock market performance
Desirable brands that generate Pricing Power and therefore stock market performance

Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.

Read more
MORE NEWS